Founded in early 2005, StratiCELL is a leading company assisting the cosmetic, pharmaceutical and chemical industries to the safety and efficacy evaluation of their actives and products by means of in vitro models and methods in a GLP-compliant environment.
StratiCELL is a skin model manufacturer and a project-driven services provider for in vitro testing, with a particular emphasis on testing of skin care actives and products
Wound Healing & Angiogenesis
Wound healing properties of actives are addressed using in vitro tests targeting cell proliferation (BrdU incorporation assay), migration ("scratch" assay, Boyden chambers,...) and invasion (Boyden chambers) and sequential expression of tissue repair markers (cytokine secretion, protease activities,...). The effect of an active on angiogenesis -the formation of tubular vessel- can also be evaluated in vitro by a co-culture assay mimicking the in vivo interactions between fibroblasts and endothelial cells during proliferation phase.
